Development and in vivo evaluation of intranasal formulations of parathyroid hormone (1-34)

References

• Agu RU, Valiveti S, Earles DC, et al. (2004). Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in rats . Endocr Res 30:455–67.
   PubMed Web of Science ®Google Scholar
• Brayden DJ, Bzik VA, Lewis AL, Illum L. (2012). CriticalSorb™ promotes permeation of flux markers across isolated rat intestinal mucosae and Caco-2 monolayers. Pharm Res 29:2543–54.
   PubMed Web of Science ®Google Scholar
• Busch S, Unruh T. (2011). The influence of additives on the nanoscopic dynamics of the phospholipid dimyristoylphosphatidylcholine. Biochim Biophys Acta 1808:199–208.
   PubMed Web of Science ®Google Scholar
• Chappell DL, Lee AY, Castro-Perez J, et al. (2014). An ultrasensitive method for the quantitation of active and inactive GLP-1 in human plasma via immunoaffinity LC-MS/MS. Bioanalysis 6:33–42.
   PubMed Web of Science ®Google Scholar
• Colombo G, Roccatano D, Mark AE. (2002). Folding and stability of the three-stranded beta-sheet peptide Betanova: insights from molecular dynamics simulations. Proteins Struct Funct Genet 46:380–92.
   PubMed Web of Science ®Google Scholar
• Davis SS. (2001). Nasal vaccines. Adv Drug Deliv Rev 51:21–42.
   PubMed Web of Science ®Google Scholar
• Dhuria SV, Hanson LR, Frey WH. (2010). Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99:1654–73.
   PubMed Web of Science ®Google Scholar
• Djupesland PG. (2013). Nasal drug delivery devices: Characteristics and performance in a clinical perspective – a review. Drug Deliv Transl Res 3:42–62.
   PubMed Web of Science ®Google Scholar
• Dobnig H. (2004). A review of teriparatide and its clinical efficacy in the treatment of osteoporosis. Expert Opin Pharmacother 5:1153–62.
   PubMed Web of Science ®Google Scholar
• du Plessis LH, Kotze AF, Junginger HE. (2010). Nasal and rectal delivery of insulin with chitosan and n-trimethyl chitosan chloride. Drug Deliv 17:399–407.
   PubMed Web of Science ®Google Scholar
• Fabrizio B, Giulia BA, Fabio S, et al. (2009). In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate. Eur J Pharm Sci 37:36–42.
   PubMed Web of Science ®Google Scholar
• Fortuna A, Alves G, Serralheiro A, et al. (2014). Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules. Eur J Pharm Biopharm 88:8–27.
   PubMed Web of Science ®Google Scholar
• Illum L, Jordan F, Lewis AL. (2012). CriticalSorb: a novel efficient nasal delivery system for human growth hormone based on Solutol HS15. J Control Release 162:194–200.
   PubMed Web of Science ®Google Scholar
• Illum L. (2002). Nasal drug delivery: new developments and strategies. Drug Discov Today 7:1184–9.
   PubMed Web of Science ®Google Scholar
• Illum L. (2012). Nasal drug delivery – recent developments and future prospects. J Control Release 161:254–63.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Odén A, McCloskey EV, et al., IOF Working Group on Epidemiology and Quality of Life. (2012). A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239–56.
   PubMed Web of Science ®Google Scholar
• Karasulu HY, Sanal ZE, Sözer S, et al. (2008). Permeation studies of indomethacin from different emulsions for nasal delivery and their possible anti-inflammatory effects. AAPS PharmSciTech 9:342–8.
   PubMed Web of Science ®Google Scholar
• Kay RG, Hands JT, Hawthorne G, et al. (2015). Validation of an ultrasensitive LC-MS/MS method for PTH 1-34 in porcine plasma to support a solid dose PK study. Bioanalysis 7:1435–45.
   PubMed Web of Science ®Google Scholar
• Law SL, Huang KJ, Chou VHY. (2003). Stability of desmopressin loaded in liposomes. J Liposome Res 13:269–77.
   PubMed Web of Science ®Google Scholar
• Lewis AL, Jordan F, Illum L. (2013). CriticalSorb™: enabling systemic delivery of macromolecules via the nasal route. Drug Deliv Transl Res 3:26–32.
   PubMed Web of Science ®Google Scholar
• Longenecker JP, Moses AC, Flier JS, et al. (1987). Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. J Pharm Sci 76:351–5.
   PubMed Web of Science ®Google Scholar
• Maitani T, Yamamoto Y, Takayama T, Nagai K. (1995). The effect of soybean-derived sterol and its glucoside as an enhancer of nasal absorption of insulin in rabbits in vitro and in vivo. Int J Pharm 117:129–37.
   Web of Science ®Google Scholar
• Matsumoto T, Shiraki M, Hagino H, et al. (2006). Daily nasal spray of hPTH(1-34) for 3 months increases bone mass in osteoporotic subjects: a pilot study. Osteoporos Int 17:1532–8.
   PubMed Web of Science ®Google Scholar
• Neer RM, Arnaud CD, Zanchetta JR, et al. (2001). Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–41.
   PubMed Web of Science ®Google Scholar
• Neubert H, Muirhead D, Kabir M, et al. (2013). Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factor. Anal Chem 85:1719–26.
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Illum L. (1990). Absorbtion of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine. Crit Rev Ther Drug Carrier Syst 7:35–97.
   PubMed Web of Science ®Google Scholar
• Ohtake K, Natsume H, Ueda H, Morimoto Y. (2002). Analysis of transient and reversible effects of poly-L-arginine on the in vivo nasal absorption of FITch-dextran in rats. J Control Release 82:263–75.
   PubMed Web of Science ®Google Scholar
• Onoue S, Yamamoto K, Kawabata Y, et al. (2009). Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery. Int J Pharm 382:144–50.
   PubMed Web of Science ®Google Scholar
• Ozsoy Y, Gungor S, Cevher E. (2009). Nasal delivery of high molecular weight drugs. Molecules 14:3754–79.
   PubMed Web of Science ®Google Scholar
• Pearson RG, Masud T, Blackshaw E, et al. (2019). Nasal administration and plasma pharmacokinetics of parathyroid hormone peptide PTH 1-34 for the treatment of osteoporosis. Pharmaceutics 11:265.
   PubMed Web of Science ®Google Scholar
• Pires A, Fortuna A, Alves G, Falcão A. (2009). Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci 12:288–311.
   PubMed Web of Science ®Google Scholar
• Reardon PM, Gochoco CH, Audus KL, et al. (1993). In vitro nasal transport across ovine mucosa: effects of ammonium glycyrrhizinate on electrical properties and permeability of growth hormone releasing peptide, mannitol and Lucifer yellow. Pharm Res 10:553–61.
   PubMed Web of Science ®Google Scholar
• Rohrer J, Lupo N, Bernkop-Schnürch A. (2018). Advanced formulations for intranasal delivery of biologics. Int J Pharm 553:8–20.
   PubMed Web of Science ®Google Scholar
• Sato K. (2007). [Therapeutic agents for disorders of bone and calcium metabolism. Development of nasal formulation of hPTH (1-34)]). Clin Calcium 17:64–71.
   PubMedGoogle Scholar
• Satterwhite J, Heathman M, Miller PD, et al. (2010). Pharmacokinetics of Teriparatide (rhPTH[1–34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis. Calcif Tissue Int 87:485–92.
   PubMed Web of Science ®Google Scholar
• Shao Z, Mitra AK. (1992). Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: correlation with facilitated drug transport. Pharm Res 9:1184–9.
   PubMed Web of Science ®Google Scholar
• Shinichiro H, Takatsuka Y, Hiroyuki M. (1981). Effect of surfactants on the nasal absorption of insulin in rats. Int J Pharm 9:165–72.
   Google Scholar
• Shubber S, Vllasaliu D, Rauch C, et al. (2015). Mechanism of mucosal permeability enhancement of CriticalSorb® (Solutol® HS15) investigated in vitro in cell cultures. Pharm Res 32:516–27.
   PubMed Web of Science ®Google Scholar
• Suwalsky M, Mennickent S, Norris B, et al. (2006). Effects of the antiepileptic drug carbamazepine on human erythrocytes. Toxicol in Vitro 20:1363–9.
   PubMed Web of Science ®Google Scholar
• Wang J, Sakai S, Deguchi Y, et al. (2002). Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats. J Pharm Pharmacol 54:181–8.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Tsurui K, Yoneyama S, et al. (2018). Effect of dosing frequency of teriparatide (PTH 1-34) on bone formation in rats: Comparison of bone metabolism marker levels. J Toxicol Sci 43:435–42.
   PubMed Web of Science ®Google Scholar
• Williams AJ, Jordan F, King G, et al. (2018). In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis. Int J Pharm 535:113–9.
   PubMed Web of Science ®Google Scholar